NAGESWARA GUNTUPALLI: Open Payments
NPI 1790886174 · COVINA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 13 payments from 4 companies in 2025. Trend: 2023 $79 · 2024 $253 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $161 |
| ABBVIE INC. | 5 | $85 |
| Alkermes, Inc. | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, INGREZZA.
Industry payments across CA — which companies pay providers there.
